title: Sub-Regional Assessment of HPV Vaccination Among Female Adolescents in the Intermountain West and Implications for Intervention Opportunities.
abstract: Objectives We investigated the similarities and differences in the factors related to human papillomavirus (HPV) vaccination of female adolescents in three sub-regions of the Intermountain West (IW). Methods We analyzed 2011-2012 National Immunization Survey-Teen data. Respondents (parents) who were living in the IW and who had daughters aged 13-17 years old with provider-verified immunization records were included in our analyses. East, Central, and West sub-regions were defined based on geographic contiguity and similarity in HPV vaccination rates and sociodemographic characteristics. Survey-weighted Chi square tests and multivariable Poisson regressions were performed. Results In all three sub-regions, older teen age and receipt of other recommended adolescent vaccinations were significantly associated with HPV vaccination. In the East sub-region, providers' facility type and source of vaccines were significantly related to HPV vaccination. In the Central sub-region, teens with married parents were significantly less likely to be vaccinated than were those with unmarried parents. In the West sub-region, non-Hispanic teens were significantly less likely to be vaccinated than were Hispanic teens. Conclusions for Practice In order to improve HPV vaccine coverage in the IW, region-wide efforts to target younger teens and to promote the HPV vaccine with other recommended adolescent vaccinations should be supplemented with sub-regional attention to the health care system (East sub-region), to married parents (Central sub-region), and to non-Hispanic teens (West sub-region).
authors.affiliation: Cancer Control and Population Sciences, Huntsman Cancer Institute, 2000 Circle of Hope, Salt Lake City, UT, 84112, USA. Julia.Bodson@hci.utah.edu.|Huntsman Cancer Institute, 2000 Circle of Hope, Room 4127, Salt Lake City, Utah, 84112, USA. Julia.Bodson@hci.utah.edu.
authors.forename: Julia
authors.initials: J
authors.lastname: Bodson
authors.affiliation: Study Design and Biostatistics Center, School of Medicine, University of Utah, 295 Chipeta Way, Salt Lake City, Utah, 84112, USA.
authors.forename: Qian
authors.initials: Q
authors.lastname: Ding
authors.affiliation: Cancer Control and Population Sciences, Huntsman Cancer Institute, 2000 Circle of Hope, Salt Lake City, UT, 84112, USA.|College of Nursing, University of Utah, 10 South 2000 East, Salt Lake City, Utah, 84112, USA.
authors.forename: Echo L
authors.initials: EL
authors.lastname: Warner
authors.affiliation: Genetic Science Learning Center, University of Utah, 515 East 100 South, 5th Floor, Salt Lake City, Utah, 84102, USA.
authors.forename: Amy J
authors.initials: AJ
authors.lastname: Hawkins
authors.affiliation: Department of Geography, Temple University, 1115 West Polett Walk, Philadelphia, Pennsylvania, 19122, USA.|Cancer Prevention and Control Program, Fox Chase Cancer Center, 333 Cottmann Ave, Philadelphia, Pennsylvania, 19111, USA.
authors.forename: Kevin A
authors.initials: KA
authors.lastname: Henry
authors.affiliation: Cancer Control and Population Sciences, Huntsman Cancer Institute, 2000 Circle of Hope, Salt Lake City, UT, 84112, USA.|College of Nursing, University of Utah, 10 South 2000 East, Salt Lake City, Utah, 84112, USA.
authors.forename: Deanna
authors.initials: D
authors.lastname: Kepka
mesh_terms: D000293:Adolescent; D000328:Adult; D002648:Child; D005260:Female; D019538:Health Care Surveys; D006630:Hispanic or Latino / Q000706:statistics & numerical data*; D006801:Humans; D007114:Immunization; D007115:Immunization Schedule; D009679:Nuclear Family; D030361:Papillomavirus Infections / Q000208:ethnology* / Q000517:prevention & control; D053918:Papillomavirus Vaccines / Q000008:administration & dosage*; D010290:Parents; D012959:Socioeconomic Factors; D014481:United States; D014611:Vaccination / Q000706:statistics & numerical data*
chemical_list: D053918:Papillomavirus Vaccines
keywords: Adolescent; Cancer; Female; Human papillomavirus; Prevention; Vaccine